Catalent to Provide Fill-Finish Manufacturing for Moderna COVID-19 Vaccine

Moderna has named Catalent for the large-scale commercial fill-finish manufacturing vaccine candidate
$CTLT $MRNA $JNJ $AZN $ARCT #coronastocks #investors #Business #nasdaq https://t.co/FBLhhug2sn https://t.co/Z4VpoWttEk